The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.


AZN ASTRAZENECA PLC ORD SHS $0.25

ASTRAZENECA  Currency  GBX  Premium Equity Commercial Companies



 Page 10 of 11

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next |

Time/Date Code Headline Source Impact
17:20 24-Apr-2014 AZN Result of AGM RNS +12.62% Up
07:08 24-Apr-2014 AZN 1st Quarter Results - Part 2 RNS +12.62% Up
07:08 24-Apr-2014 AZN 1st Quarter Results RNS +12.62% Up
09:00 23-Apr-2014 AZN Notice of Results RNS +13.13% Up
14:00 01-Apr-2014 AZN Director/PDMR Shareholding RNS -0.46% Down
11:00 01-Apr-2014 AZN Total Voting Rights RNS -0.46% Down
14:00 31-Mar-2014 AZN Director/PDMR Shareholding RNS +0.29% Up
14:00 31-Mar-2014 AZN Director/PDMR Shareholding RNS +0.29% Up
14:00 31-Mar-2014 AZN Director/PDMR Shareholding RNS +0.29% Up
11:00 26-Mar-2014 AZN Director/PDMR Shareholding RNS +0.30% Up
07:00 21-Mar-2014 AZN Filing of Annual Report on Form 20-F with SEC RNS -1.42% Down
11:00 20-Mar-2014 AZN Annual Financial Report RNS -1.39% Down
11:00 20-Mar-2014 AZN Directorate Change RNS -1.39% Down
15:00 19-Mar-2014 AZN Director/PDMR Shareholding RNS -1.41% Down
07:00 12-Mar-2014 AZN AstraZeneca announces sale of Alderley Park site RNS -0.92% Down
16:00 03-Mar-2014 AZN Total Voting Rights RNS -1.21% Down
07:00 03-Mar-2014 AZN US FDA APPROVES BYDUREON® PEN RNS -1.21% Down
18:24 25-Feb-2014 AZN FDA Approves Orphan Drug Myalept RNS +0.65% Up
15:30 12-Feb-2014 AZN Director/PDMR Shareholding RNS +3.55% Up
17:00 11-Feb-2014 AZN Director/PDMR Shareholding RNS +4.30% Up

 Page 10 of 11

Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Next |

Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released, including the day of the release of the news
y = instrument's latest 7 closing prices before the news was released

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank " - " next to the line indicating the RNS issue.


ASTRAZENECA share - news analysis

The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds